RT @DrCassySims: Whatâs new to treat PsA? Letâs discuss anti-IL-17A, Izokibep #ACR22 @RheumNow Abstract #0199 ð
Tweet Content
What’s new to treat PsA? Let’s discuss anti-IL-17A, Izokibep #ACR22 @RheumNow
Abstract #0199
💪 Izokibep 40 v. 80 mg q2 weeks SQ v. placebo
💪 135 patients, 28 sites
💪 At 12 weeks, all patient reported outcomes and PsAID subdomains significantly improved (dose dependent)
Show on Archive Page
On
Display in Search Results
On
PDQ
Off